VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SNGX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SNGXSoligenix, Inc.
$0.25$4M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSNGXBalance Sheet

Soligenix, Inc. (SNGX) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial stability is increasingly fragile, with total assets contracting from $11.3 million in 2025Q3 to $6.9 million in 2026Q1, alongside an accumulated deficit of $247.9 million.

Income StatementBalance SheetCash FlowRatios

SNGX Balance Sheet

Annual statement

SNGX Balance Sheet

Soligenix, Inc. (SNGX) balance sheet — 30-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets9.17M8.85M8.83M9.51M13.85M26.57M19.47M7.49M10.34M9.42M10.11M7.15M6.49M7.61M3.84M7.13M8.01M7.9M1.92M2.44M304.04K1.52M3.13M4.29M4.25M10.04M13.03M8.65M15M17.4M1.07M
Cash & Short-Term Investments9.02M7.94M7.82M8.45M13.36M26.04M18.68M5.42M8.98M7.81M8.77M4.92M5.53M5.86M3.36M6M7.45M7.69M1.48M2.22M119.64K821.7K2.33M4.12M4.15M9.94M12.85M8.54M12.2M15.7M1.02M
Cash Only9.02M7.94M7.82M8.45M13.36M26.04M18.68M5.42M8.98M7.81M8.77M4.92M5.53M5.86M3.36M6M7.45M7.69M1.48M2.22M119.64K821.7K2.33M4.12M4.15M9.94M10.83M5M12.2M15.7M1.02M
Short-Term Investments000000000000000000000000002.01M3.55M000
Accounts Receivable000195.15K219.33K242.72K564.87K1.46M1.2M1.34M1.21M1.99M794.77K1.62M339.31K936.63K372.65K23.63K278.32K97.84K89.93K564.33K742.99K20.95K0000000
Days Sales Outstanding----320.222.66K106.8166.0583.6990.2542.1582.6441.19183.1239.3844.6169.823.0643.9828.3914.1966.96271.8791.25-------
Inventory0000000000000000042.87K82.18K000000000000
Days Inventory Outstanding-----------------10.5415.9------------
Other Current Assets6.42K912.85K1.01M866.01K274.21K000000000000000000000185.34K102.55K2.8M1.7M0
Total Non-Current Assets297.38K386.51K137.85K290.01K426.56K300.41K424.23K282.04K148.99K133.85K153.33K236.1K461.46K656.38K868.72K1.09M1.26M1.48M1.44M1.35M1.1M1.85M1.93M1.96M1.59M1.01M637.87K625.83K1.2M1.7M369.25K
Property, Plant & Equipment274.6K354.96K115.08K241.76K359.47K128.38K251.54K161.5K19.63K37.16K26.7K47.37K51.51K23.87K12.99K15.03K20.7K21.17K21.22K25.94K29.69K44.73K50.48K60.8K262.92K365.22K384.16K448.95K500K100K183.58K
Fixed Asset Turnover0.00x---0.70x0.26x7.67x19.91x266.93x146.17x391.32x185.11x136.73x135.08x242.02x509.78x94.11x133.01x108.87x48.49x77.90x68.77x19.76x1.38x----0.40x1.00x-
Goodwill0000000000000000000000000000000
Intangible Assets00000023.25K19.7K46.86K73.95K126.63K188.73K409.95K632.51K855.73K1.08M1.24M1.46M1.42M1.32M1.07M1.8M1.88M1.9M1.32M639.96K253.71K176.88K400K300K185.67K
Long-Term Investments00000073.14K000000000000000000000000
Other Non-Current Assets22.78K31.55K22.78K48.24K67.1K172.03K172.69K100.83K82.5K22.73K0000-868.72K0000000000000300K1.3M0
Total Assets9.46M9.24M8.97M9.8M14.28M26.87M19.89M7.78M10.49M9.55M10.27M7.39M6.95M8.27M4.71M8.22M9.27M9.38M3.36M3.78M1.41M3.37M5.07M6.25M5.84M11.04M13.67M9.27M16.2M19.1M1.44M
Asset Turnover0.00x---0.02x0.00x0.10x0.41x0.50x0.57x1.02x1.19x1.01x0.39x0.67x0.93x0.21x0.30x0.69x0.33x1.64x0.91x0.20x0.01x----0.01x0.01x-
Asset Growth %58.44%3%-8.48%-31.39%-46.86%35.08%155.82%-25.89%9.86%-6.99%38.99%6.22%-15.86%75.67%-42.79%-11.27%-1.23%179.07%-11.13%168.94%-58.28%-33.45%-18.94%7.09%-47.13%-19.22%47.43%-42.76%-15.18%1230.39%-
Total Current Liabilities3.06M3.7M4.85M6.15M16.52M6.29M6.08M6.31M4.21M3.23M2.87M7.41M7.11M10.04M1.15M1.43M1.91M1.21M1.39M1.19M2.52M1.84M2.08M1.01M1.2M3.27M2.92M1.73M1.1M600K57.48K
Accounts Payable1.71M1.12M667.9K1.11M3.87M2.93M2.13M2.74M2.13M1.75M1.71M2.87M3M1.52M1.12M1.3M1.67M844.86K1.02M847.61K2.11M1.53M1.67M531.59K698.12K856.19K642.44K496.89K500K600K0
Days Payables Outstanding144.7K-2.04K546.592.56K1.47K426.92279.88168.78148.5173.92152.18206.3218.12158.29225.71373.06207.8196.44327.94392.39270.33650.382.55K---1.49K-128.81-107.35-438-
Short-Term Debt001.37M2.25M9.9M0324.98K0000292.72K0000000000115.95K359.07K382.12K164.75K118.79K110.34K100K00
Deferred Revenue (Current)00000000000298.68K-3.47M000000000000000000
Other Current Liabilities0488.13K336.44K2.42M336.69K302.94K0298.17K0002.43M3.79M8.28M0000000165K100K002.25M2.16M1.13M500K057.48K
Current Ratio3.00x2.39x1.82x1.55x0.84x4.22x3.20x1.19x2.46x2.92x3.52x0.97x0.91x0.76x3.32x4.98x4.19x6.53x1.39x2.04x0.12x0.83x1.50x4.26x3.53x3.07x4.46x4.99x13.64x29.00x18.55x
Quick Ratio3.00x2.39x1.82x1.55x0.84x4.22x3.20x1.19x2.46x2.92x3.52x0.97x0.91x0.76x3.32x4.98x4.19x6.49x1.33x2.04x0.12x0.83x1.50x4.26x3.53x3.07x4.46x4.99x13.64x29.00x18.55x
Cash Conversion Cycle------------------194.19-136.55------------
Total Non-Current Liabilities150.05K244.12K01.12M233.67K9.86M10.07M6.15K0000000000000000347.85K10.4M204.16K281.9K400K100K0
Long-Term Debt0001.01M09.86M9.95M00000000000000000347.85K52.1K204.16K281.9K300K00
Capital Lease Obligations789.67K244.12K0111.86K233.63K0116.3K6.15K00000000000000000000000
Deferred Tax Liabilities0000000000000000000000000000000
Other Non-Current Liabilities000043-1000000000000000000010.35M00-100K100K0
Total Liabilities3.21M3.94M4.85M7.27M16.75M16.15M16.15M6.32M4.21M3.23M2.87M7.41M7.11M10.04M1.15M1.43M1.91M1.21M1.39M1.19M2.52M1.84M2.08M1.01M1.55M13.67M3.12M2.02M1.5M700K57.48K
Total Debt273.92K358.14K1.48M3.49M10.24M9.96M10.51M127.22K000292.72K3.79M000000000115.95K359.07K729.97K216.85K322.95K392.24K400K00
Net Debt-8.75M-7.58M-6.33M-4.95M-3.12M-16.08M-8.17M-5.29M-8.98M-7.81M-8.77M-4.63M-1.74M-5.86M-3.36M-6M-7.45M-7.69M-1.48M-2.22M-119.64K-821.7K-2.22M-3.76M-3.42M-9.73M-10.51M-4.6M-11.8M-15.7M-1.02M
Debt / Equity0.04x0.07x0.36x1.39x-0.93x2.81x0.09x--------------0.04x0.07x0.17x-0.03x0.05x0.03x--
Debt / EBITDA-0.03x------------------------------
Net Debt / EBITDA0.89x------------------------------
Interest Coverage----156.20x-17.18x-13.83x-1701.39x-----886.87x-----10285.71x-2252.43x-1054.95x------409.24x-409.24x-----
Total Equity6.26M5.29M4.12M2.52M-2.47M10.72M3.74M1.46M6.28M6.32M7.4M-18.31K-153.89K-1.77M3.55M6.79M7.36M8.17M1.98M2.59M-1.11M1.53M2.98M5.24M4.29M-2.63M10.55M7.26M14.7M18.4M1.38M
Equity Growth %259.73%28.51%63.26%202.09%-123.04%186.56%156.79%-76.8%-0.63%-14.57%40502.25%88.1%91.3%-149.84%-47.71%-7.7%-9.99%313.44%-23.67%333.69%-172.54%-48.78%-43.11%22.38%263.02%-124.93%45.34%-50.64%-20.11%1235.08%-
Book Value per Share0.281.022.485.20-13.7757.7132.6718.05114.37246.85495.40-1.69-16.39-274.6947.8392.96109.062342.8658.2285.69-52.1692.19220.32539.20571.49-586.432595.022024.034429.0417574.02815.98
Total Shareholders' Equity6.26M5.29M4.12M2.52M-2.47M10.72M3.74M1.46M6.28M6.32M7.4M-18.31K-153.89K-1.77M3.55M6.79M7.36M8.17M1.98M2.59M-1.11M1.53M2.98M5.24M4.29M-2.63M10.55M7.26M6.3M18.4M1.38M
Common Stock23.37K10.09K2.51K10.38K2.91K2.86K30.64K21.75K17.68K8.73K5.47K31.27K23.94K19.63K11.17K11.11K216.19K185.66K118.61K95K68.86K50.61K42.22K34.89K26.8K20.95K12.86K10.88K005.9K
Retained Earnings-250.98M-245.05M-233.97M-225.7M-219.56M-205.77M-193.21M-175.53M-166.17M-157.27M-150.12M-146.88M-139.05M-132.34M-122.28M-118.12M-115.74M-108.35M-102.32M-98.9M-92.73M-84.57M-79.85M-73.98M-68.69M-63.72M-49.09M-44.29M-35.3M-13.5M-8.26M
Treasury Stock0000000000000000000000-427.7K-468.27K-468.27K-443.75K-443.75K-443.75K-400K0-443.75K
Accumulated OCI45.79K45.79K45.79K22.24K24.75K41.94K-24.34K-45.01K-3.67K0000000-20.02K-13.28K-132.6K0-111.18K0-68.15K-141.65K386.66K1.69M-4.78K-649.04K-900K-900K0
Minority Interest00000000000000000000000000008.4M00

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and regulatory insolvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Erosion Reflects Stagnation

According to quarterly filings, Soligenix has seen its total assets decline from $11.3 million in 2025Q3 to $6.9 million by 2026Q1, a contraction that highlights the company's inability to replenish its resource base through commercial success while it continues to fund ongoing clinical development programs.

The consistent downward trend in total assets suggests that the company is consuming its capital base to sustain operations without achieving a corresponding increase in value-creating assets. This trajectory implies that the business model remains entirely dependent on external capital infusions to prevent further erosion of its financial foundation.

Tightening Runway Limits Operational Flexibility

As reported in recent financial statements, the company's cash position has dwindled to $6.0 million as of 2026Q1, down from $10.5 million in 2025Q3, which significantly constrains the firm's ability to navigate potential regulatory delays or unexpected clinical trial costs without seeking immediate dilutive financing.

While the current ratio of 1.81 appears superficially adequate, the lack of recurring revenue means that this liquidity buffer is rapidly depleting. Investors should monitor the burn rate closely, as the current cash position provides a very narrow margin of safety for a company with high fixed R&D requirements.

Equity Quality Diluted by Losses

Based on the company's balance sheet data, shareholders' equity has experienced significant volatility, dropping to $3.1 million in 2026Q1 from a peak of $7.6 million in 2025Q3, a trend driven by the accumulation of massive retained losses totaling approximately $247.9 million over the firm's history.

The persistent negative retained earnings indicate that the company has failed to generate profitable returns on invested capital, forcing a reliance on equity issuance that dilutes existing shareholders. This structural weakness suggests that the equity base is primarily a reflection of past capital raises rather than accumulated operational value.

Debt Levels Mask Underlying Fragility

Although total debt remains relatively low at $330.7K as of 2026Q1, the D/E ratio has fluctuated wildly, reaching as high as 4.17 in 2024Q1, which indicates that even minor debt obligations can disproportionately impact the company's leverage profile given its extremely thin equity base.

The low absolute debt levels should not be interpreted as financial strength, as the company's primary risk is not insolvency from debt service but rather the exhaustion of cash required to fund operations. The volatility in the D/E ratio serves as a warning that the company's capital structure is highly sensitive to changes in equity valuation and cash reserves.

SNGX — Frequently Asked Questions

Quick answers to the most common questions about buying SNGX stock.

What are the total assets of Soligenix, Inc. (SNGX)?

As of 2025, Soligenix, Inc. (SNGX) had total assets of $9.2M including $8.8M in current assets.

How much debt does Soligenix, Inc. (SNGX) have?

Soligenix, Inc. (SNGX) carries total debt of $0.4M, offset by $7.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Soligenix, Inc.?

Soligenix, Inc. (SNGX) has total shareholders' equity (book value) of $5.3M ($1.02 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Soligenix, Inc.'s current ratio and liquidity?

Soligenix, Inc. (SNGX) reported a current ratio of 2.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.